Cat. No. 5236
Chemical Name: (1R,5S)-1,2,3,4,5,6-Hexahydro-3-[2-
Biological ActivityHigh affinity and subtype selective α6β2 and α4β2 partial agonist (Ki values are 12 and 26nM for rat α6β2 and α4β2 receptors respectively). Has low affinity for α3β4 and α7 receptors (Ki values are 4.8 and 13 μM for human α3β4 and rat α7 receptors respectively). Stimulates dopamine release from striatal slices in vitro. Attenuates nicotine-induced self-administration and conditional place preference in rats.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
Sala et al (2013) CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Br.J.Pharmacol. 168 835. PMID: 22957729.
Riganti et al (2005) Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Br.J.Pharmacol. 146 1096. PMID: 16273122.
Carbonnelle et al (2003) Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes. Eur.J.Pharmacol. 471 85. PMID: 12818695.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses CC4 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: CC4, supplier, CC4, high, affinity, subtype, selective, partial, agonist, acetylcholine, nicotinic, receptors, alpha4beta2, a4b2, α4β2, alpha6beta3, a6b3, α6β3, Tocris Bioscience, Nicotinic (α4β2) Receptor Agonist products